IRBESARTAN/HCT SANDOZ 300/12.5 irbesartan 300 mg/hydrochlorothiazide 12.5 mg film-coated tablet bottle Australija - anglų - Department of Health (Therapeutic Goods Administration)

irbesartan/hct sandoz 300/12.5 irbesartan 300 mg/hydrochlorothiazide 12.5 mg film-coated tablet bottle

sandoz pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; croscarmellose sodium; iron oxide red; purified talc; macrogol 6000; titanium dioxide; microcrystalline cellulose; hypromellose; magnesium stearate; iron oxide yellow; hyprolose - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

IRBESARTAN HCT MYLAN 300/12.5 irbesartan/hydrochlorothiazide 300/12.5 mg tablet bottle Australija - anglų - Department of Health (Therapeutic Goods Administration)

irbesartan hct mylan 300/12.5 irbesartan/hydrochlorothiazide 300/12.5 mg tablet bottle

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: sodium lauryl sulfate; povidone; croscarmellose sodium; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; quinoline yellow aluminium lake; pregelatinised maize starch; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 3350; iron oxide black - abisart hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

IRBESARTAN HCT MYLAN 150/12.5 irbesartan/hydrochlorothiazide 150/12.5 mg tablet bottle Australija - anglų - Department of Health (Therapeutic Goods Administration)

irbesartan hct mylan 150/12.5 irbesartan/hydrochlorothiazide 150/12.5 mg tablet bottle

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet - excipient ingredients: povidone; microcrystalline cellulose; magnesium stearate; sodium lauryl sulfate; pregelatinised maize starch; colloidal anhydrous silica; croscarmellose sodium; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 3350; iron oxide black - abisart hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

APO-IRBESARTAN HCTZ 300/12.5 irbesartan and hydrochlorothiazide 300/12.5mg tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 300/12.5 irbesartan and hydrochlorothiazide 300/12.5mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; croscarmellose sodium; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000 - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

APO-IRBESARTAN HCTZ 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; lactose monohydrate; croscarmellose sodium; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000 - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Irbesartan HCTZ MLabs 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablets blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

irbesartan hctz mlabs 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablets blister pack

micro labs pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: povidone; colloidal anhydrous silica; mannitol; iron oxide red; iron oxide yellow; sodium starch glycollate type b; magnesium stearate; polysorbate 80; hypromellose; titanium dioxide; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

BTC IRBESARTAN HCTZ 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

btc irbesartan hctz 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; mannitol; polysorbate 80; sodium starch glycollate type b; hypromellose; magnesium stearate; povidone; titanium dioxide; iron oxide yellow; iron oxide red; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

APX-IRBESARTAN HCTZ 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

apx-irbesartan hctz 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type b; mannitol; povidone; magnesium stearate; hypromellose; colloidal anhydrous silica; polysorbate 80; titanium dioxide; iron oxide yellow; iron oxide red; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

IRBESARTAN HCTZ ARROW 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

irbesartan hctz arrow 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: poloxamer; povidone; croscarmellose sodium; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; pregelatinised maize starch; lactose monohydrate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

IRBESARTAN HCTZ ARROW 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

irbesartan hctz arrow 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; lactose monohydrate; pregelatinised maize starch; poloxamer; croscarmellose sodium; microcrystalline cellulose; povidone; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed dose combination.